摘要
目的:应用心脉龙注射夜治疗肺心病患者,观察其对血液动力学效应,评价其临床疗效。方法:30例肺心病代偿期伴右心室单纯性舒张功能不全患者应用心脉龙注射液(A组),另60例肺心病心衰Ⅱ°患者,随机分为30例心脉龙注射液组(B组)及30例对照组(地高辛+酚妥拉明,C组)。采用SPECT心血池动态显像术,测右心室收缩功能及舒张功能,对比观察药物对肺心病患者的血液动力学效应,同时观察心率、血压、肝肾功能。结果:A组治疗后舒张功能显著改善(P<005或P<001);B组治疗后收缩、舒张功能均有显著改善(P<005或P<001)。B与C组比较治疗后收缩、舒张功能相应值均有显著差异(P<005或P<001)。结论:心脉龙对肺心病心衰有极好的血液动力学效应,对心率、血压、肝肾功能无影响,该药有临床应用价值。
OBJECTIVE:Patients with cor pulmonale were treated with Xinmailong injections to observe their hemodynamic changes in order to evaluate its clinical efficacy. METHODS: Patients enrolled into the study were equally divided into three groups:group A:30 patients with right ventricular diastolic disfunction were treated with Xinmailong. Group B and C: Each consisted of 30 patients with IIphase right heart failure. Group B were treated with Xinmailong and group C were treated with digoxin+regitin. Before and after treatment, the following parameters were measured by SPECT blood pool ventriculography: RVEF(right ventricular ejection fraction); 1/3 EF(1/3 ejection fraction); 1/3ER (1/3 ejection rate); PFR(peek filling rate); 1/3 FR(1/3 filling rate); and 1/3FF (1/3 filling fraction). RESULTS:After treatment, diastolic function were significantly improved in group A patients and also markedly improved in group B patients. The systolic and diastolic function were markedly improved in group B patients in comparison with those in group C patients. CONCLUSION:Xinmailong is a promising drug for treatment of cor pulmonale with heart failure on the basis of hemodynamic changes and without effects on heart rate, blood pressure and liver functions.
出处
《中国新药杂志》
CAS
CSCD
1998年第2期137-141,共5页
Chinese Journal of New Drugs
基金
云南省科委应用基础研究基金
关键词
心脉龙
肺心病
血液动力学
Cor pulmonale
Hemodynamics
Xinmalong
Blood pool radionuclide ventriculography